Happy Thanksgiving, everyone! Or at least, Happy Thanksgiving to the Americans among you — I know I missed the Canadian Thanksgiving by a month or so, and I hope everyone else around the world has had a chance to give thanks for whatever it is that makes your life meaningful.
Personally, part of what makes my life fun and meaningful is this — writing about stocks and newsletters for you. And I thought today would be an opportune time to revisit some stinkers … and to choose the Turkey of the Year, and perhaps even carve it up a bit for you.
This honor is not bestowed lightly — to be named Turkey of the Year in Gumshoedom, you must have been a truly awful stock idea, chosen within the last twelve months, and, preferably, you should stand for all that is entertaining (and misleading) in stock newsletter teaser ads.
And within the last twelve months there have been a half dozen or so picks that are down at least 90%, so there was no shortage of candidates. If you went back to look at the whole history of Gumshoe Mania on the spreadsheets, adding another nine months or so of picks to that last year covered herein, you’d have even more options — roughly 10% of the stocks I’ve written about in this space are down by 90% or more, and a few rare delights have fallen even more drastically still: Centerline Holdings (which even looked promising to me way back when, before the mortgage meltdown) and Atherogenix are both down fully 99% from the price when they were touted, and there are several well-known stocks that were popular with the Gumshoe faithful that got immolated — Crocs and Neuro-Hitech both got a lot of attention in this space, and both are down by about 98% as I type.
Neither of those was picked within the last twelve months though, at least not for the first time, so the winner of the Turkey of the Year is … Read the rest of this entry »
Recent Comments